FDA Inspection 1173018 — Laboratory Corporation of America Holdings
The FDA completed an inspection of Laboratory Corporation of America Holdings on June 15, 2022 in Raritan, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 15, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Raritan, NJ (United States)